title: Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
abstract: The relative contribution of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)4 and ADAMTS5 to aggrecan degradation under oncostatin M (OSM) stimulation, the role of the ancillary domains of the aggrecanases on their ability to cleave within the chondroitin sulfate (CS)-2 region, the role of hyaluronidases (HYAL) in stimulating aggrecan release in the absence of proteolysis, and the identity of the hyaluronidase involved in OSM-mediated cartilage breakdown were investigated. Bovine articular cartilage explants were cultured in the presence of interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNFalpha) and/or OSM, or treated with trypsin and/or hyaluronidase. Aggrecan was digested with various domain-truncated isoforms of ADAMTS4 and ADAMTS5. Aggrecan and link protein degradation and release were analyzed by immunoblotting. Aggrecanase and HYAL gene expression were determined. ADAMTS4 was the most inducible aggrecanase upon cytokine stimulation, whereas ADAMTS5 was the most abundant aggrecanase. ADAMTS5 was the most active aggrecanase and was responsible for the generation of an OSM-specific degradation pattern in the CS-2 region. Its ability to cleave at the OSM-specific site adjacent to the aggrecan G3 region was enhanced by truncation of the C-terminal thrombospondin domain, but reduced by further truncation of both the spacer and cysteine-rich domains of the enzyme. OSM has the ability to mediate proteoglycan release through hyaluronan degradation, under conditions where HYAL-2 is the predominant hyaluronidase being expressed. Compared to other catabolic cytokines, OSM exhibits a unique potential at degrading the proteoglycan aggregate, by promoting early robust aggrecanolysis, primarily through the action of ADAMTS5, and hyaluronan degradation.
authors.affiliation: Shriners Hospital or Children and McGill University, Montreal, Quebec H3G 1A6, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Durigova
authors.forename: L
authors.initials: L
authors.lastname: Troeberg
authors.forename: H
authors.initials: H
authors.lastname: Nagase
authors.forename: P J
authors.initials: PJ
authors.lastname: Roughley
authors.forename: J S
authors.initials: JS
authors.lastname: Mort
mesh_terms: D051722:ADAM Proteins / Q000378:metabolism*; D053674:Aggrecans / Q000378:metabolism*; D000818:Animals; D002358:Cartilage, Articular / Q000378:metabolism*; D002417:Cattle; D002478:Cells, Cultured; D002809:Chondroitin Sulfates / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D006821:Hyaluronoglucosaminidase / Q000235:genetics / Q000378:metabolism*; D015151:Immunoblotting; D053583:Interleukin-1beta / Q000378:metabolism; D045726:Metalloproteases / Q000235:genetics / Q000378:metabolism; D053683:Oncostatin M / Q000378:metabolism*; D010003:Osteoarthritis / Q000378:metabolism; D020033:Protein Isoforms; D019699:Thrombospondins / Q000235:genetics / Q000378:metabolism; D046509:Tissue Culture Techniques; D014357:Trypsin / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D053674:Aggrecans; D016207:Cytokines; D053583:Interleukin-1beta; D020033:Protein Isoforms; D019699:Thrombospondins; D014409:Tumor Necrosis Factor-alpha; D053683:Oncostatin M; D002809:Chondroitin Sulfates; D006821:Hyaluronoglucosaminidase; D045726:Metalloproteases; D014357:Trypsin; D051722:ADAM Proteins